Pure Global

Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire - Trial NCT05796193

Access comprehensive clinical trial information for NCT05796193 through Pure Global AI's free database. This phase not specified trial is sponsored by London School of Hygiene and Tropical Medicine and is currently Not yet recruiting. The study focuses on Malaria. Target enrollment is 1650 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05796193
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05796193
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire

Study Focus

Malaria

Alpha-cypermethrin and PBO LLIN

Interventional

other

Sponsor & Location

London School of Hygiene and Tropical Medicine

Timeline & Enrollment

N/A

Jul 01, 2023

Dec 01, 2024

1650 participants

Primary Outcome

malaria case incidence by malaria rapid diagnostic test HRP2/pLDH [pf/pan]

Summary

The investigator plan to conduct a three-arm cluster-randomized control trial which compares
 two next generation of long-lasting Insecticidal Nets (LLINs); VeeralinยฎLLIN (PBO-py LLIN),
 Interceptor G2 (chlorfenapyr-py LLIN) to a standard py-LLIN in the department of Tiebissou
 Southern Bouake city, central Cรดte d'Ivoire.
 
 The primary objective of the project is to evaluate the efficacy of chlorfenapyr-pyrethroid
 and piperonyl-butoxide (PBO) synergist-pyrethroid LLINs on malaria case incidence in children
 aged 6 months to 10 years compared to standard pyrethroid-only LLINs. The secondary
 objectives are to evaluate the efficacy of the two intervention LLINs compared to the
 standard LLIN on a) malaria infection prevalence in the general population (both children and
 adults), b) vector density and c) entomological inoculation rate (EIR) (as a proxy for
 malaria transmission). In addition, changes in phenotypic resistance intensity and selection
 for molecular resistance mechanisms at baseline and 12 months post-LLIN distribution, in
 sentinel villages in each treatment arm will be investigate.
 
 It is vital to demonstrate that these next generation LLINs which are becoming the standard
 of care in Sub Saharan AFRICA, are superior to standard py-LLIN in the most extreme
 resistance areas as this is likely where alternative interventions will be most needed to
 keep malaria control on track. The trial will generate the first epidemiological evidence on
 the efficacy of PBO nets compared to py-LLIN in West Africa.

ICD-10 Classifications

Unspecified malaria
Plasmodium malariae malaria
Plasmodium falciparum malaria
Other parasitologically confirmed malaria
Plasmodium ovale malaria

Data Source

ClinicalTrials.gov

NCT05796193

Non-Device Trial